Review of the upper airway, including olfaction, as mediator of symptoms. by Shusterman, Dennis
The upper airway, including nasal cavity, phar-
ynx, and larynx, is the gateway to the respira-
tory tract (Figure 1). In that role, it fulfills
several functions, including air conditioning,
ﬁltering, sensation, and communication (Table
1). Adverse effects from air pollutants may
affect the upper airway as the target or trigger
other adaptations indirectly (Table 2). Central
to the understanding of pollutant-related
health effects is an appreciation of the anatomy
and physiology of the upper respiratory tract.
Under most climatic conditions, inspired
air is heated (to 37°C) and humidified (to
near 100% relative humidity) in the upper
airway (1). Filtration is accomplished
mechanically by nasal vibrissae and by the
process of impaction whereby large-diameter-
inspired particles collide with the turbinates
and are subsequently cleared by the mucocil-
iary apparatus. In the case of aerosols carrying
infectious agents, the mucosa produce both
speciﬁc and nonspeciﬁc defenses, the former
including secretory IgA and the latter includ-
ing lactoferrin and lysozyme (2). Water-solu-
ble irritants, including ammonia, chlorine,
and various organic acids and aldehydes in
cigarette smoke, readily dissolve in the
mucous membrane layer of the cornea and
upper airway (“scrubbing”), thus protecting
the lower respiratory tract during nasal
breathing (3). In this process the eyes, nose,
and throat are irritated, serving as a warning
to reduce exposure (Figure 2). Air pollutants
vary in their relative irritant and odorant
potencies, such that odor and irritation may
be experienced singly or in combination,
depending on the specific compound(s)
involved, the exposure level(s), duration, and
the sensory characteristics of the individual
who is exposed (4,5).
In terms of sensation, the nasal cavity is
innervated by two main structures: the olfac-
tory nerve (cranial nerve I, providing for the
sense of smell), and the trigeminal nerve
(cranial nerve V, providing for the sense of
irritation, also referred to as chemesthesis or
the common chemical sense) (Figure 3). In
addition, the glossopharyngeal and vagal
nerves (cranial nerves IX and X) convey the
sense of irritation for the hypopharynx and
larynx. Just as our appreciation of foods
involves a combination of the senses of taste,
smell, and mucosal irritation, our apprecia-
tion of many inhaled compounds involves
aspects of olfaction and trigeminal stimula-
tion (6). The latter carries sensations ranging
from freshness or tingling (e.g., in response to
menthol) to burning or stinging (as elicited
by ammonia or chlorine). Because the cornea,
another structure vulnerable to environmen-
tal irritants, is also innervated by the trigemi-
nal nerve, eye irritation is often grouped with
upper respiratory tract irritation for purposes
of discussion. Specialized psychophysical
methods have been developed to quantitate
both threshold and suprathreshold percep-
tions in olfaction and chemesthesis (7,8).
These techniques are important adjuncts to
studying chemically mediated symptoms in
both clinical and experimental settings.
The Upper Airway as a Target
Nonallergic Rhinitis
The relationship between irritant rhinitis and
other types of nonallergic rhinitis is not fully
defined. Despite inconsistent terminology
(so-called vasomotor rhinitis, noneosinophilic
nonallergic rhinitis, and nonallergic, nonin-
fectious perennial rhinitis), all include in their
description an exaggerated reactivity to com-
mon physical and chemical stimuli. Patients
frequently report congestion or rhinorrhea in
response to changes in air temperature or
humidity, exposure to bright lights, exercise,
consumption of alcohol, or exposure to per-
fumes, household cleaning products, or envi-
ronmental tobacco smoke (9). Pharmacologic
challenge (with methacholine or histamine),
as well as challenge with cold, dry air, have
been used to demonstrate differences in
responsiveness among various rhinitic sub-
groups and controls (10–12). Unfortunately,
the subtypes of nonallergic rhinitis, as well as
the concept of nasal hyperreactivity, still lack
consensus deﬁnitions.
Limited insight into nonallergic response
mechanisms does exist, however. In both
experimental animals and humans, activation
of upper respiratory tract irritant receptors
may trigger a variety of airway reflexes,
including sneezing, rhinorrhea, nasal conges-
tion, cough, laryngeal constriction, and
bronchoconstriction (13). Although most of
these reﬂexes have potential protective func-
tions, they may be troublesome if present in
an exaggerated form. Theories explaining
augmented nasal reﬂex symptoms in nonaller-
gic rhinitis include sensory hyperesthesia,
cholinergic hyperreactivity, and sympathetic
hyporeactivity. Limited data distinguish
among these alternatives; however, based
upon challenge studies and the use of cholin-
ergic blockers, the parasympathetic nervous
system appears to be involved in at least the
secretory component of this disorder (14).
Local (axon) reﬂexes, involving release of sub-
stance P and other neuropeptides, may also
be operative (15).
Irritant-Induced Rhinitis
Also relevant in this context is the hypothesis
that a one-time exposure to an irritant can ini-
tiate irritant rhinitis, similar to the situation for
irritant-induced asthma, or reactive airways
dysfunction syndrome (RADS) (16). One
investigator suggested that irritant-induced
rhinitis be termed reactive upper airways dys-
function syndrome or RUDS (17). Biopsies of
the nasal mucosa among individuals acutely
exposed to irritants have reportedly shown
epithelial desquamation, defective epithelial
cell junctions, and increased numbers of nerve
ﬁbers, although patients and controls did not
differ in staining for neuropeptides (18).
Individuals with a history of persistent upper
airway symptoms after irritant exposures who
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Unexplained Symptoms
The upper airway serves as air conditioner, ﬁlter, and warning device. Two neurological modali-
ties, olfaction and trigeminal chemoreception, inform us of the chemical qualities of the air we
breathe. A number of poorly understood conditions, including nonallergic rhinitis, irritant-
induced rhinitis, odor-triggered asthma, odor-triggered panic attacks, chemical-induced olfactory
dysfunction, and irritant-associated vocal cord dysfunction, involve induction of symptoms by
odorant and/or irritant chemicals in the upper airway. This article is a summary of the knowledge
and theories about these various conditions, and highlights those aspects of nasal anatomy, physi-
ology, and pathophysiology relevant to their understanding. Key words: air pollutants, asthma,
irritants, olfaction, panic disorder, rhinitis, trigeminal chemoreception, unexplained symptoms,
vocal cord dysfunction. Environ Health Perspect 110(suppl 4):649–653 (2002).
http://ehpnet1.niehs.nih.gov/docs/2002/suppl-4/649-653shusterman/abstract.html650 VOLUME 110 | SUPPLEMENT 4 | AUGUST 2002 • Environmental Health Perspectives
have also complained of multisystem reactivity
to low-level chemical exposures have been
labeled “chemically sensitive,” and it has been
suggested that they have either increased levels
of circulating neuropeptides (19) or have
undergone “neurogenic switching,” in which
airway inﬂammation encourages inﬂammation
in other organ systems (20). Unfortunately,
the number of testable hypotheses that have
emerged from this literature is scant, and it is
unclear that the individuals in these case series
have clinical presentations beyond the scope of
more conventional diagnoses, including the
more descriptive “irritant rhinitis” (21).
Irritant-Associated Vocal Cord
Dysfunction
Vocal cord dysfunction (VCD), an episodic
disorder also referred to as “paradoxical vocal
cord motion,” can produce a variety of symp-
toms, including throat tightness (globus),
stridor, and laryngeal wheezing (often
mistaken for asthma). The hallmark of the
condition is the finding on laryngoscopy of
inappropriate adduction of the vocal cords
(folds) during inspiration (Figure 4). In addi-
tion to an oft-cited connection with psycho-
logical factors, there is increasing evidence that
inflammatory conditions, including both
rhinitis/sinusitis with chronic postnasal drip as
well as gastroesophageal reflux disease
(GERD), can initiate or exacerbate this condi-
tion (22). Recent work suggests that some
individuals may also manifest VCD symptoms
after exposure to airborne irritants as an initiat-
ing and/or triggering event (so-called irritant-
associated vocal cord dysfunction) (23).
Chemically Induced Olfactory
Dysfunction
Workplace exposure to a number of irritant
chemicals has been associated with subjective
and objective olfactory loss. Among these
agents are cadmium (battery workers and bra-
ziers), hydrocarbons (paint formulators and
tank cleaners), and ammonia and sulfuric
acid (chemical plant workers). Because most
affected occupational cohorts have been stud-
ied cross-sectionally only, little can be said
about the natural history of such impairment
(24). In addition both hydrogen sulfide and
the various mercaptans can produce profound
olfactory fatigue of a transient nature.
Potential mechanisms of chemically induced
olfactory impairment include direct toxicity
to the olfactory epithelium, injury to the cen-
tral nervous system proper, and impaired
delivery of odorants to the olfactory epithe-
lium (due to congestion and high-grade air-
flow obstruction). Olfactory loss can have
important health implications, including
impaired ability to recognize food spoilage,
failure to detect gas leaks, and impaired abil-
ity to detect respirator cartridge breakthrough
(for workers required to wear respirators)
(25). Distorted olfactory perception (dysos-
mia), which can occur after either viral or
chemical insult, may produce not only neg-
ative hedonic responses but also frank alarm
and secondary autonomic activation in
some individuals (see discussion of multiple
chemical sensitivities below).
The Upper Airway as Mediator
of Symptoms
Odor-Triggered Asthma
Asthma is a medical condition in which indi-
viduals are widely believed to be more sensi-
tive to odors (26–30). Shim and Williams
found that 90% of a group of 60 asthmatic
individuals surveyed reported exacerbations of
Unexplained Symptoms • Shusterman
Sinuses:
Frontal
Sphenoid
Turbinates:
Superior
Middle
Inferior
Eustachian tube opening
Palette/uvula
Epiglottis
Larynx
Figure 1. Principal anatomical features of the upper
respiratory tract.
Table 1. Functions of the upper airway.
General Speciﬁc
Air conditioning Heating
Humidiﬁcation
Air ﬁltration Microbes (inactivation)
Particulates (mucociliary
clearance)
Vapors (scrubbing)
Sensation Olfaction (odor perception)
Chemesthesis (irritant perception)
Communication Hearing (pressure regulation of
the middle ear)
Speech (phonation)
Table 2. Role of upper airway in symptom complexes.
Condition Target Mediator
Nonallergic rhintitis X
Irritant-induced rhinitis X
Chemically induced  X
olfactory dysfunction
Irritant-induced vocal  X
cord dysfunction
Odor-triggered asthma X
Odor-triggered panic attacks X
Water
solubility
Initial level
of impact Compounds
Eyes
Nose
Pharynx
Larynx
Aldehydes
Ammonia
Chlorine
Sulfur
  dioxide
Trachea
Bronchi
Ozone
Bronchioles
Alveoli
Nitrogen
  dioxide
Phosgene
High
Medium
Low
Figure 2. Effect of water solubility of a gas or vapor
on initial site of mucous membrane irritation.
Adapted from U.S. DHHS (3).
Cranial nerve I
Cranial
nerve V
Figure 3. Anatomical distribution of the ﬁrst (olfac-
tory) and ﬁfth (trigeminal) cranial nerves within the
upper airway.
Figure 4. Laryngoscopic images of vocal cords
(folds) during expiration (A) and inspiration (B) in a
patient with irritant-associated vocal cord dysfunc-
tion. Note paradoxical adduction (closure) of cords
during inspiration. Images courtesy of C. Gress,
University of California, San Francisco/Mt. Zion
Voice Center.Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 4 | AUGUST 2002 651
asthma related to odorant exposures, and
nearly 40% had visited emergency depart-
ments after such incidents. One quarter of
respondents also reported nasal symptoms
(congestion, sneezing) during odorant expo-
sures. In this same publication (29), the
authors reported on a small-scale experiment
in which four asthmatic individuals were
exposed to aerosolized cologne for 10 min;
there were significant acute drops in forced
expiratory volume in 1 sec (FEV1) in all sub-
jects. On repeat testing, pretreatment with
placebo (saline) had no effect on these pul-
monary function changes, whereas pretreat-
ment with atropine or metaproteronol either
blunted them or prevented them entirely. Use
of a nose clip prevented pulmonary function
changes in only one of three subjects tested
(29). The finding of significant acute pul-
monary function changes despite the use of a
nose clip implies a direct, possibly irritant,
action on the bronchial epithelium by the test
agent (cologne) used. Some of the odorants
listed in the survey (tobacco smoke, house-
hold cleaning products) clearly had irritant
properties as well. 
Along this same line of investigation,
Kumar and colleagues (30) exposed 29 asth-
matic individuals and 13 normal controls to
filter-paper strips containing a) saline
placebo, b) 70% isopropyl alcohol (IPA), or
c) a commercial perfume, as well as to strips
from a magazine containing that same per-
fume. Asthmatic individuals varied in their
disease severity from mild to severe, and skin-
prick testing confirmed a lack of immuno-
logic reaction to the perfume employed in all
but three of the experimental subjects. For
both delivery modes, the perfume exposure
produced signiﬁcant declines in FEV1 in the
asthmatic group compared with that in con-
trols, with smaller changes being documented
after IPA exposure alone. One in five asth-
matic individuals complained of chest tight-
ness, wheezing, and rhinitis after perfume
challenge, whereas none complained of such
symptoms after IPA exposure. Significantly,
the magnitude of perfume-related pulmonary
function decrements was related to the
baseline severity of subjects’ asthma (30).
These studies underscore the degree to
which environmental stimuli, including
those usually identified as odorants, may
exacerbate asthma. Differentiation of odor-
versus irritant-related changes in pulmonary
function, however, may require special atten-
tion by researchers. Reference to animal
experimental data in which respiratory
behavior alterations can be seen in response
to irritant exposure may provide ancillary
information for selected chemical
compounds of interest (31–34).
Odor-Triggered Panic Attacks
Shusterman and colleagues (35) previously
reported two cases of intolerance to specific
odorants (industrial chemicals) that devel-
oped after a one-time overexposure involving
signiﬁcant respiratory tract irritation. In each
case the worker tolerated the compound’s
odor prior to the incident but found him/her-
self experiencing symptoms of hyperventila-
tion (air hunger, lightheadedness, acrodigital
paresthesias, anxiety) upon exposure to the
compound subsequent to the overexposure.
In each case serious respiratory tract pathol-
ogy was ruled out. A mechanism of respon-
dent (Pavlovian) conditioning was postulated
(Figure 5) (35). Similar cases had previously
been labeled “atypical posttraumatic stress
disorder” by Schottenfeld and Cullen (36),
and an analogous mechanism was subse-
quently proposed for episodic “neurotoxic”
symptoms (37).
Dager and colleagues (38) reported
another series of patients in which individuals
ﬁrst showed paniclike symptoms when work-
ing with solvents in enclosed spaces. In con-
trast to the irritant-exposed patients, these
individuals were hypothesized to have experi-
enced a mild solvent narcosis, with a subse-
quent lowering of their threshold for a panic
response (Figure 6). These cases (solvent
related) and the above-described postirritant
exposures were subsequently reviewed by
Shusterman and Dager, who suggested the
uniform terminology of “odor-triggered panic
attacks.” This label was proposed for cases
exhibiting episodic dyspnea coupled with
central nervous system (CNS) and autonomic
symptoms meeting the criteria for panic
attacks, and occurring in response to per-
ceived environmental odors, regardless of the
prior exposure history (39).
Several recent studies have examined the
potential contribution of olfaction and
olfactory-related central nervous system
reflexes in so-called multiple chemical sensi-
tivities (MCS) or idiopathic environmental
intolerance (IEI). Doty and colleagues (40)
compared odor detection thresholds from
18 patients with a diagnosis of MCS versus
a group of suitably matched controls and
found no difference between the two groups
(i.e., MCS patients were apparently hyper-
reactors rather than hyperperceivers). In
terms of defining these reactions, compari-
son of episodic symptoms reported in
MCS/IEI and those reported in panic disor-
der shows considerable overlap (Table 3). In
their original 1987 study, Dager et al. (38)
conducted intravenous sodium lactate chal-
lenges on three patients with “panic disor-
der precipitated by exposure to organic
solvents,” and all three responded with
typical panic symptoms.
More recently Binkley and Kutcher (41)
studied ﬁve patients with a diagnosis of MCS
and found that all met the DSM-IV criteria
for panic disorder and also responded with
paniclike symptoms to intravenous sodium
lactate infusion. Lenzoff and Binkley chal-
lenged 15 MCS patients with identiﬁed trig-
ger substances; 11 patients responded with
acute hyperventilation, as evidenced by a fall
in end-tidal CO2 levels (42). Finally, Poonai
and colleagues conducted CO2 inhalation
challenges on 36 subjects with IEI and 37
healthy controls (see accompanying article by
Tarlo). The two groups differed signiﬁcantly
in their scores on the Anxiety Sensitivity
Index (IEI subjects scoring higher), and sig-
nificantly more IEI than control subjects
reacted to CO2 provocation with paniclike
symptoms (71 vs. 26%; p < 0.001) (43).
Mechanistically, Wood reviewed the use of
inhalants as conditioned and unconditioned
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Figure 5. Model for respondent (Pavlovian) condi-
tioning to compounds with both irritant and odorant
properties. UCS, unconditioned stimulus; CS, con-
ditioned stimulus. Reproduced from Shusterman
and Dager (39) with permission from Hanley and
Belfus Publishers.
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Figure 6. Model for psychobiologic induction of
panic attacks by weakly narcotic agents (e.g., sol-
vent vapors). Dotted line represents threshold for
panic, which is hypothesized to be altered by nar-
cotic state. Once initial panic attack has occurred,
this model postulates a perpetuation of lowered
threshold, either by conditioning or by neural kin-
dling. Reproduced from Shusterman and Dager (39)
with permission from Hanley and Belfus
Publishers.
Table 3. Comparison of acute symptoms in MCS/IEI
and panic disorder.
Symptom MCS/IEIa Panicb
Acute mental status changes X X
Lightheadedness X X
Dyspnea/air hunger X X
Paresthesias X X
Palpitations X X
Nausea X X
Sweating X X
Headache X –
aData from Cone et al. (55). bData from APA (56).stimuli in animal behavior studies (44) and
pointed out that as early as the 1920s and
1930s, odorants were studied as conditioned
stimuli (45,46). Unconditioned, irritant-
related changes in respiratory behavior have
been documented in both experimental ani-
mals (47) and humans (48–50). Of relevance
here, recent work by Van den Berg’s group in
Belgium has examined learning paradigms in
which subirritant levels of CO2 are used as an
unconditioned stimulus for hyperventilation,
and various inhaled odorants (again, at nomi-
nally subirritant levels) as conditioned stimuli.
In general, both symptoms (dyspnea) and res-
piratory behavior (increased respiratory fre-
quency) can be conditioned to an odorant
exposure after a relatively small number of
acquisition trials. Although pretrial, uncondi-
tioned odor responses appear to have little role
in the above outcomes, negative-valency odors
are much more efficient conditioned stimuli
than positive-valency odors (51–53).
To summarize the evidence pertaining to
odor-triggered anxiety states:
• Clinical observations of individuals involved
in traumatic (irritant) respiratory tract over-
exposures suggest that the same exposure
agent, at lower (odorant) concentrations,
may subsequently trigger symptoms of
anxiety and hyperventilation.
• Similar symptom patterns can be observed
among individuals working with CNS toxi-
cants (e.g., solvents with acute, reversible
narcotic effects), including a clinical presen-
tation indistinguishable from classic panic
disorder.
• Conditioning experiments with human vol-
unteers suggest that odors, particularly from
compounds with intrinsic irritancy, can
acquire a signal value when presented with
an unconditioned stimulus for hyperventila-
tion, and that both symptoms and altered
respiratory behavior can subsequently be
elicited by the test odorant alone.
• There is some clinical/experimental evi-
dence that the episodic symptom complex
of MCS/IEI may involve hyperventilation
and/or panic and may occur on an odor-
triggered basis.
Summary
Air pollutants, including compounds with
predominantly odorant qualities, may trigger
symptoms locally in (and reﬂexively from) the
upper respiratory tract. Symptoms may be as
straightforward as mucous membrane irrita-
tion, or as nebulous as mental status changes.
A frequent component of unexplained symp-
tom complexes is the complaint of dyspnea,
or shortness of breath. As noted in Figure 7,
three conditions—asthma, VCD, and panic
attacks—have as an essential feature the com-
plaint of episodic dyspnea. Careful history-
taking, including a description of the dyspnea
(“do you have trouble getting air in or out?”),
associated glottic symptoms (globus, hoarse-
ness, stridor), and associated autonomic/CNS
symptoms (paresthesias, palpitations, sweat-
ing, chest pain, gastrointestinal distress, sensa-
tion of depersonalization/derealization, sense
of impending doom) may assist in this some-
times difficult differential diagnosis (54).
Other poorly understood symptom com-
plexes involving the upper airway, including
nonallergic rhinitis and irritant-induced
rhinitis, remain to be elucidated in terms of
both mechanism and strict case deﬁnition.
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